Bayer

Bayer(BAYRY)

LEVERKUSEN, Germany
Pharmaceutical61 H-1B visas (FY2023)

Focus: Biotech / Pharma / Chemical Giant

Error: Unreachable/Blocked

OncologyCardiovascularHematologyOphthalmology
Funding Stage
PUBLIC
Employees
100,000
Open Jobs
4

Products & Portfolio (23)

27 discontinued products not shown

ADEMPAS
riociguat
Peak
ORAL · TABLET
Guanylate Cyclase Stimulators
inoperable CTEPH to improve exercise capacityfunctional class(WHO Group 4) after surgical treatment+5 more
2013
0
ALEVE
naproxen sodium
LOE Approaching
ORAL · TABLET
minor achespains due to: minor pain of arthritis muscular aches backache menstrual cramps headache toothache the common cold temporarily reduces fever
1994
30
ALEVE PM
diphenhydramine hydrochloride and naproxen sodium
Peak
ORAL · TABLET
2014
30
ANGELIQ
drospirenone and estradiol
Peak
ORAL · TABLET
Estrogen Receptor Agonists
moderate to severe vasomotor symptoms due to menopause in a woman with a uterusmoderate to severe vasomotor symptoms associated due to menopause in a woman with a uterusmoderate to severe symptoms of vulvar+2 more
2005
0
ASTEPRO ALLERGY
azelastine hcl
LOE Approaching
NASAL · SPRAY, METERED
2021
15
BETASERON
interferon beta-1b
LOE Approaching
SUBCUTANEOUS · VIAL
(interferon beta-1b) in patients with multiple sclerosis is unknown.
relapsing forms of multiple sclerosisto include clinically isolated syndromerelapsing-remitting disease+2 more
1993
30
BEYAZ
drospirenone/ethinyl estradiol/levomefolate calcium and levomefolate calcium
Peak
ORAL · TABLET
ovulation.
symptoms of premenstrual dysphoric disorder (PMDD) in females of reproductive potentialmoderate acne vulgaris in females of reproductive potential at least 14 years of agefemales of reproductive potential+5 more
2010
8
CHILDREN'S ASTEPRO ALLERGY
azelastine hcl
LOE Approaching
NASAL · SPRAY, METERED
2021
15
CHILDREN'S CLARITIN
loratadine
LOE Approaching
ORAL · TABLET, CHEWABLE
these symptoms due to hay feverother upper respiratory allergies:
2006
30
CIPRO
ciprofloxacin
LOE Approaching
ORAL · FOR SUSPENSION
[see Microbiology ()].
plagueincluding pneumonicsepticemic plague+37 more
1997
45
CLARITIN
loratadine
LOE Approaching
ORAL · CAPSULE
these symptoms due to hay feverother upper respiratory allergies: runny nose itchywatery eyes sneezing itching of the nose+1 more
2008
30
CLARITIN
loratadine
LOE Approaching
ORAL · TABLET, CHEWABLE
these symptoms due to hay feverother upper respiratory allergies:
2006
30
View all 23 products

Pipeline & Clinical Trials

No Intervention
Chronic Kidney Disease
N/A
Clinical Trials (5)
NCT05004428A Study to Learn More About Chronic Kidney Disease (CKD) in Patients With Type 2 Diabetes Mellitus (T2DM)
N/A
NCT04010240A Retrospective Study to Determine the Incidence of NTRK Fusions. NTRK Study
N/A
NCT03605810Study to Develop a Tool to Estimate the Kidney Function in Databases Without Laboratory Data
N/A

+2 more

N/A
Clinical Trials (5)
NCT02305238Japanese Treat and Extend Study of Aflibercept in Neovascular Age-related Macular Degeneration
Phase 4
NCT03169660Intravitreal Aflibercept for Submacular Hemorrhage
Phase 4
NCT02072408Efficacy and Safety of Intravitreal Vascular Endothelial Growth Factor Trap-eye in Patients With Polyploidal Choroidal Vasculopathy
Phase 4

+2 more

Clinical Trials (5)
NCT02822261Sun Protection Factor Assay
N/A
NCT02803060Sun Protection Factor Assay
N/A
NCT0275156718776 - Human Photoallergy Test
N/A

+2 more

N/A
Clinical Trials (5)
NCT038410324 Week In-Use Study Evaluating How Well-Tolerated a Skin Care Product Is on Adults With Facial Redness
N/A
NCT0275701418613 - Sun Protection Factor Assay
N/A
NCT0277982918432-Sun Protection Factor Assay
N/A

+2 more

N/A
Clinical Trials (5)
NCT05797376Effects of aSPIrin Versus Aspirin Plus Low-dose RIvaroxaban on Carotid aTherosclerotic Plaque Inflammation
Phase 4
NCT04853719Rivaroxaban 2.5 mg BID and Aspirin for Intermittent Claudication in PAD Patients
Phase 4
NCT04073316AntiCoagulants and COGnition
Phase 4

+2 more

Damoctocog alfa pegol
Hemophilia A
N/A
Clinical Trials (5)
NCT04085458Study to Gain More Information on How Safe and Effective Jivi Works in Patients With Severe Hemophilia A (Post-marketing Investigation)
Phase 4
NCT05147662A Study to Learn How Safe the Study Treatment BAY94-9027 is and How it Affects the Body in Previously Treated Children Aged 7 to Less Than 12 Years With Severe Hemophilia A, a Genetic Bleeding Disorder That is Caused by the Lack of a Protein Called Clotting Factor 8 (FVIII) in the Blood
Phase 3
NCT03932201Evaluating Effectiveness and Long Term Safety of Damoctocog Alfa Pegol in Patients, Who Have Been Diagnosed With Hemophilia A
N/A

+2 more

Clinical Trials (5)
NCT00352859Phase IV Randomization to On-Going Treatment to Evaluate Sustained Sorafenib
Phase 4
NCT00494299Phase III Study of BAY43-9006 in Patients With Advanced Hepatocellular Carcinoma (HCC) Treated After Transcatheter Arterial Chemoembolization (TACE)
Phase 3
NCT00625378Sorafenib Long Term Extension Program
Phase 3

+2 more

Clinical Trials (5)
NCT04565236A Post Approval Commitment Study to Gain More Information on How Safe and Effective KOVALTRY is in Chinese Children, Adolescents /Adults With Severe Hemophilia A
Phase 4
NCT01311648BAY81-8973 Pediatric Safety and Efficacy Trial
Phase 3
NCT02941783Drug Use Investigation of Kovaltry in Hemophilia A Patients
N/A

+2 more

N/A
Clinical Trials (1)
NCT02822300Sun Protection Factor Assay
N/A
Cognitive evaluation
Multiple Sclerosis
N/A
Clinical Trials (1)
NCT02391064Validation of Brief Computerized Cognitive Assessment in Multiple Sclerosis (BCCAMS)
N/A
Lanthanum Carbonate
Hyperphosphatemia
N/A
Clinical Trials (5)
NCT02237534Lanthanum Versus Calcium Carbonate for Vascular Abnormalities in Patients With CKD and Hyperphosphatemia
Phase 4
NCT01110629Study in Chronic Kidney Disease (CKD) Not on Dialysis
Phase 3
NCT01518387Open Study of BAY77-1931 (Lanthanum Carbonate) in Continuous Ambulatory Peritoneal Dialysis Patients
Phase 3

+2 more

N/A
Clinical Trials (1)
NCT03556787An Evaluation of a Gender Specific Insole to Provide Relief From Knee Pain Due to Osteoarthritis or General Anterior Knee Pain in Male Subjects When Used in Foot Wear Over a Period of Four Weeks
N/A
Clinical Trials (5)
NCT05658458A Study to Learn How Well the Drug Vericiguat Works and How Safe it is Under Real World Conditions in Indian Participants After Worsening of a Long-term Heart Condition in Which the Left Side of the Heart Does Not Pump Blood as Well as it Should (Chronic Heart Failure With Reduced Ejection Fraction)
Phase 4
NCT01951638Phase IIb Safety and Efficacy Study of Four Dose Regimens of BAY1021189 in Patients With Heart Failure and Preserved Ejection Fraction Suffering From Worsening Chronic Heart Failure (SOCRATES-PRESERVED)
Phase 2
NCT01951625Phase IIb Safety and Efficacy Study of Four Dose Regimens of BAY1021189 in Patients With Heart Failure With Reduced Ejection Fraction Suffering From Worsening Chronic Heart Failure (SOCRATES-REDUCED)
Phase 2

+2 more

N/A
Clinical Trials (4)
NCT01740687A Study to Evaluate the Effectiveness of Essure Post-NovaSure Radiofrequency Endometrial Ablation Procedure Following a Successful Essure Confirmation Test
N/A
NCT02532361Proportion of Hysterectomy After Female Sterilization
N/A
NCT02510443Observational Study on Contraception With Essure in France
N/A

+1 more

Interferon-1beta
Multiple Sclerosis
N/A
Clinical Trials (1)
NCT00461396Success of Titration, Analgesics, and B.E.T.A Nurse Support on Acceptance Rates in Early Multiple Sclerosis (MS) Treatment With Betaseron
N/A
BAY14-2222_Kogenate-FS FVIII
Hemophilia A
N/A
Clinical Trials (1)
NCT02263066Retrospective Study in Chinese Pediatric Hemophilia A Patients With rFⅧ Contained Regular Prophylaxis
N/A
Levonorgestrel
Menorrhagia
N/A
Clinical Trials (5)
NCT02957292A Study to Compare the Menstrual Bleeding Profile Among Jaydess® and Copper Intrauterine Device (IUD) Users. COLIBRI STUDY (Copper and Levonorgestrel IUD Barcelona Research Initiative).
Phase 4
NCT02362373Women With Epilepsy: a Pilot Study of PK and PD Anti-epileptic Drug Effects in Levonorgestrel Intrauterine System Users
Phase 4
NCT00393198Bleeding Pattern and User Satisfaction During Second Consecutive MIRENA® in Contraception and Treatment of Menorrhagia
Phase 4

+2 more

Patients with Atrial Fibrillation
Atrial Fibrillation
N/A
Clinical Trials (1)
NCT04099238Burden of Ischemic Stroke and Intake of Oral Anticoagulants in Patients With Atrial Fibrillation in the UK Primary Care
N/A
N/A
Clinical Trials (1)
NCT0271735118841- Sun Protection Factor Assay
N/A
Iopromide
Angiography
N/A
Clinical Trials (5)
NCT00244140Ultravist: Safety and Efficacy in Computed Tomography of Head and Body
Phase 3
NCT01206257The Safety and toleRability of UltraviSt in Patients Undergoing Cardiac CaTheterization (TRUST)
N/A
NCT00876083PMS Study Ultravist-IMAGE, IoproMide (UltrAvist) to Gain Further Information on Tolerability and Safety in X-ray Examination
N/A

+2 more

Levonorgestrel IUS
Idiopathic Menorrhagia
N/A
Clinical Trials (1)
NCT00868153Mirena in Idiopathic Menorrhagia
N/A
Moxifloxacin
Pneumonia
N/A
Clinical Trials (5)
NCT01302951Penetration of Moxifloxacin Into Liver Tissue of Patients Undergoing Liver Resection.
Phase 4
NCT00629135Moxifloxacin Plus Metronidazole Versus Piperacillin/Tazobactam for the Treatment of Patients With Intra-abdominal Abscesses
Phase 3
NCT00164463TBTC Study 27/28 PK: Moxifloxacin Pharmacokinetics During TB Treatment
Phase 2

+2 more

N/A
Clinical Trials (1)
NCT04519619Study to Learn More About Safety of Aflibercept Injection in Japanese Patients With Neovascular Glaucoma (NVG)
N/A
Cardiac Pathologies in Standard Thoracic CT Imaging
Coronary Artery Disease
N/A
Clinical Trials (1)
NCT02904239Cardiac Pathologies in Standard Thoracic CT Imaging
N/A
N/A
Clinical Trials (1)
NCT0280192918670 - Sun Protection Factor Assay
N/A
Abdominal US
Liver Cirrhosis
N/A
Clinical Trials (1)
NCT06312826Abbreviated MRI Using Gadoxetic Acid Versus Ultrasonography for Surveillance of Early-stage HCC in Patients at High Risk
N/A
Levonorgestrel IUS
Contraception
N/A
Clinical Trials (1)
NCT01414140Mirena Post-marketing Surveillance in Japan
N/A
N/A
Clinical Trials (2)
NCT03409588Treatment of Exercise-Induced Pulmonary Vascular Dysfunction After Pulmonary Thromboendarterectomy or Balloon Pulmonary Angioplasty
Phase 2
NCT02634203Riociguat Versus Balloon Pulmonary Angioplasty in Non-operable Chronic thromboEmbolic Pulmonary Hypertension
N/A
Clinical Trials (1)
NCT03223727Treatment Outcomes in a Non-study Population of Symptomatic mCRPC Patients Treated With Radium-223
N/A
Exhaled Breath Olfactory Signature
Pulmonary Hypertension
N/A
Clinical Trials (1)
NCT02782026Exhaled Breath Olfactory Signature of Pulmonary Arterial Hypertension
N/A
Interferon beta-1b
Multiple Sclerosis
N/A
Clinical Trials (5)
NCT01701856Natalizumab De-escalation to Interferon-beta-1b in Patients With Relapsing-remitting Multiple Sclerosis
Phase 4
NCT00313976Study to Compare Double-dose Betaferon to the Approved Dose, for Patients With Early Secondary Progressive Multiple Sclerosis (SPMS)
Phase 3
NCT00370071Open Label Study to Evaluate Effect, Safety and Tolerability of Betaferon Standard Dose of 250µg in Patients of Chinese Origin With Multiple Sclerosis
Phase 3

+2 more

Available Recombinant, and Human Factor VIII products incl. Kogenate FS
Hemophilia A
N/A
Clinical Trials (1)
NCT02396862Patient Functioning and Well-being, Economic, and Clinical Impact of Hemophilia A and Its Treatment
N/A
Clinical Trials (5)
NCT01592149Survey of Prevalence of Loss of Appetite in Subject With Health Disorders
N/A
NCT01071681Survey to Assess Why People Are Not Responding to Treatment in Hypertension
N/A
NCT04607889A Study to Learn More About What Japanese Patients With Solid Tumors Think About Taking Medicine That is Based on Their Genetic Information
N/A

+2 more

Clinical Trials (5)
NCT01413958Effects of Phenylephrine Extended-Release Tablets on Allergy-Related Nasal Congestion (P08498 AM1)
Phase 3
NCT00976209Consumer Preference Study of Two Formulations of Phenylephrine Hydrochloride (Study CL2008-15)(P07530)(COMPLETED)
Phase 3
NCT04534452Study to Find Out Whether Participants With a History of Stuffy Nose Due to Allergic Reactions in the Nose Would Intend to Buy Drug Phenylephrine Hydrochloride Extended Release Tablets After Receiving it Once in This Study
Phase 3

+2 more

Ciprofloxacin
Infection
N/A
Clinical Trials (5)
NCT00663806A Phase IV Study of Cipro XR in Uncomplicated UTI
Phase 4
NCT00669994Trial to Evaluate the Efficacy and Safety of Cipro® XR in Treating Female Patients With Lower Urinary Tract Infections
Phase 4
NCT00676533Cipro® XR in Therapeutic Response and Activity (eXtRa) - Assessing Symptom Relief in Urinary Tract Infections
Phase 4

+2 more

Observational Study of Efficacy and Safety of Travogen Cream and Travocort Cream in the Treatment of
Skin Mycoses
N/A
Clinical Trials (1)
NCT00722189Observational Study of Efficacy and Safety of Travogen Cream and Travocort Cream in the Treatment of Mycoses
N/A
Interferon-1beta
Multiple Sclerosis
N/A
Clinical Trials (1)
NCT00873340Physical Disability in Patients Treated With Betaferon
N/A
Standard of Care
Male Hypogonadism
N/A
Clinical Trials (5)
NCT03194646Assess Safety and Efficacy of Vilaprisan in Subjects With Uterine Fibroids
Phase 3
NCT00858650Registry of Hypogonadism in Men
N/A
NCT02615587Burden of Illness in Atrial Fibrillation
N/A

+2 more

Clinical Trials (4)
NCT00226512To Determine the Role of Adding Campath-1H or ATG Given In-vivo in Addition to Fludarabine and Low Dose Busulfex on Outcome in Patients Treated With Reduced Intensity Conditioning
Phase 3
NCT00142181Phase II Study of Campath-1H Antibody to Treat Waldenstrom's Macroglobulinemia
Phase 2
NCT00193466Rituximab and Fludarabine Followed by CAMPATH-1H in Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
Phase 2

+1 more

N/A
Clinical Trials (1)
NCT02803047Sun Protection Factor Assay
N/A
N/A
Clinical Trials (1)
NCT02803008Sun Protection Factor Assay
N/A
N/A
Clinical Trials (2)
NCT01331655Clinical Study of a Conventional and Flexible Extended Oral Contraceptive of EE/DRSP With or Without Metafolin in Latin America
Phase 3
NCT01198444To Evaluate Compliance to Treatment Regimen (Rate of Deviations From the Prescribed Regimen) in Polish Females Treated With Different Low Dose Oral Contraceptives
N/A
N/A
Clinical Trials (5)
NCT00927667Joint Status in Subjects With Severe Hemophilia A in Relation to Different Treatment Regimens
Phase 4
NCT01249664VEGF Trap-Eye in Choroidal Neovascularization Secondary to Pathologic Myopia (mCNV)
Phase 3
NCT01643122Validation Study for Endometriosis PRO
N/A

+2 more

Lanthanum Carbonate
Hyperphosphatemia
N/A
Clinical Trials (1)
NCT01955876Fosrenol Post-marketing Surveillance in Japan
N/A
Standard of care
Hypertension, Pulmonary
N/A
Clinical Trials (1)
NCT02637050A Study Investigating Routine Practice of Chronic Thromboembolic Pulmonary Hypertension Management in EMEA Countries
N/A
BAY 987519, SPF 50, Y51-002
Sunscreen Agents
N/A
Clinical Trials (1)
NCT02857478Supervised Outdoor-Use Test to Assess the Safety of a Sunscreen C-Spray on Sport Users
N/A
Recombinant Factor VIII
Hemophilia A
N/A
Clinical Trials (1)
NCT00922597Non-interventional Observation of Practical Implementation, Efficacy and Safety of Continuous Infusion With KOGENATE Bayer in Surgery
N/A

Open Jobs (4)

Interview Prep Quick Facts
Portfolio: 133 approved products, 220 clinical trials
Top TAs: Oncology, Cardiovascular, Neurology
H-1B (2023): 61 approvals
Publications: 25 in PubMed
Open Roles: 4 active jobs
Portfolio Health
Pre-Launch25 (19%)
Launch2 (2%)
Peak17 (13%)
LOE Approaching78 (59%)
Post-LOE11 (8%)
133 total products
Therapeutic Area Focus
Oncology
8 marketed667 pipeline
Cardiovascular
2 marketed237 pipeline
Neurology
3 marketed98 pipeline
Nephrology
79 pipeline
Women's Health
8 marketed64 pipeline
Rare Diseases
62 pipeline
Infectious Diseases
8 marketed36 pipeline
Marketed
Pipeline

Hiring Trend

Actively Hiring
4
Open Roles
+4
Added
-0
Filled/Removed

Based on last 2 crawl cycles

Visa Sponsorship

Sponsors Work Visas
H-1B Petitions (FY2023)
61
Approved
3
Denied
95%
Rate

Source: USCIS H-1B Employer Data Hub